The Hidden Cost of Consolidation: When Cancer Care Becomes a Luxury
The recent acquisition of Mission Cancer + Blood by the University of Iowa Health Care (UI Health) was touted as a win for Iowans, particularly those in rural areas. Personally, I think the promise of better access to cancer care is undoubtedly a good thing, especially in a state with the second-highest cancer rate in the country. But what many people don't realize is that this consolidation comes with a hidden cost – one that’s hitting patients hard in the wallet.
The Shocking Bill: A Personal Wake-Up Call
Let me share my own experience. As a breast cancer survivor, routine check-ups are a non-negotiable part of my life. A simple blood test and a follow-up visit with my oncologist used to be a relatively affordable part of my healthcare routine. But this year, the same visit at Mission Cancer + Blood cost me a staggering $1,991. That's a 400% increase from the previous year!
What makes this particularly fascinating is the breakdown of the bill. Only $800 was for my doctor's services. The remaining $1,192 was for the blood test – a test I could have gotten elsewhere for a fraction of the cost. This raises a deeper question: Why are patients being charged hospital rates for routine clinic procedures?
The Consolidation Conundrum: A National Trend
This isn't just an isolated incident. It's part of a disturbing national trend. When large hospital systems acquire independent clinics, they often switch to hospital-based billing, which includes facility fees. These fees, meant to cover overhead costs, can dramatically inflate the price of routine care.
In my opinion, this practice is particularly egregious when it comes to cancer care. Cancer patients are already facing immense physical and emotional challenges. Adding financial strain to the mix is simply unacceptable.
The Human Cost: Access Denied
The consequences of these skyrocketing costs are dire. A Washington Post analysis highlights the growing unaffordability of healthcare, with premiums expected to rise significantly. When routine cancer screenings and follow-up care become financially out of reach, people will inevitably delay or forgo treatment altogether. This, in my view, is a public health crisis in the making.
Beyond the Numbers: A System in Need of Reform
The UI Health acquisition of Mission Cancer + Blood is a microcosm of a larger issue – the consolidation of healthcare and its impact on affordability. While consolidation can lead to efficiencies, it shouldn't come at the expense of patient access.
One thing that immediately stands out is the lack of transparency around billing changes. Many patients, like myself, were caught off guard by the sudden increase in costs. Better communication and clearer explanations are essential.
Furthermore, we need systemic reforms. Nine states have already banned outpatient facility fees for certain procedures. Iowa should follow suit. We also need to address the root causes of rising healthcare costs, including the role of private equity firms in healthcare acquisitions.
A Call to Action: Demanding Accountability
As a journalist, I've seen firsthand the impact of these rising costs on individuals and families. It's time for a reckoning. We need to hold healthcare providers and policymakers accountable for ensuring that cancer care remains accessible and affordable for all Iowans.
This means advocating for transparency in billing practices, supporting legislation that curbs excessive fees, and demanding that our elected officials prioritize the health and well-being of their constituents over the profits of healthcare corporations. The fight for affordable cancer care is a fight for our lives.
